Department of Obstetrics and Gynecology, University of Campinas, São Paulo, Brazil.
UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research, WHO, Geneva, Switzerland.
Int J Gynaecol Obstet. 2018 May;141 Suppl 1(Suppl Suppl 1):48-54. doi: 10.1002/ijgo.12466.
To compare scores on the 36-item WHO Disability Assessment Schedule 2.0 tool (WHODAS-36) for postpartum women across a continuum of morbidity and to validate the 12-item version (WHODAS-12).
This is a secondary analysis of the Brazilian retrospective cohort study on long-term repercussions of severe maternal morbidity. We determined mean, median, and percentile values for WHODAS-36 total score and for each domain, and percentile values for WHODAS-12 total score in postpartum women divided into three groups: "no," "nonsevere," and "severe" morbidities.
The WHODAS-36 mean total scores were 11.58, 18.31, and 19.19, respectively for no, nonsevere, and severe morbidity. There was a dose-dependent effect on scores for each domain of WHODAS-36 according to the presence and severity of morbidity. The diagnostic validity of WHODAS-12 was determined by comparing it with WHODAS-36 as a "gold standard." The best cut-off point for diagnosing dysfunctionality was the 95th percentile.
The upward trend of WHODAS-36 total mean value scores of women with no morbidity compared with those with morbidity along a severity continuum may reflect the impact of morbidity on postpartum functioning.
比较残疾评估量表 2.0 工具(WHODAS-36)在不同发病严重程度的产后女性中的评分,并验证其 12 项版本(WHODAS-12)。
这是巴西一项关于严重产妇发病率长期影响的回顾性队列研究的二次分析。我们确定了 WHODAS-36 总分和每个领域的平均分、中位数和百分位数值,以及产后分为无、非严重和严重三种发病程度的 WHODAS-12 总分的百分位数值。
WHODAS-36 总评分分别为无、非严重和严重发病程度的 11.58、18.31 和 19.19。根据发病程度和严重程度,WHODAS-36 每个领域的评分都存在剂量依赖性效应。通过将 WHODAS-12 与 WHODAS-36 进行比较来确定 WHODAS-12 的诊断有效性,作为“金标准”。诊断功能障碍的最佳截断值为第 95 百分位数。
与无发病程度的女性相比,沿着发病严重程度连续体的女性 WHODAS-36 总平均分呈上升趋势,这可能反映了发病对产后功能的影响。